# Addiction Medicine Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Elvis Presley (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML003-SYN-TD
- Date: 1974-07-10
- Fictional facility: St. Posthumous Health Center
- Fictional author: Coleman Ashby-Nakagawa, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Rosalind Eberhardt-Mensah, MD, Addiction Medicine
- Urgency: Within one week, on the day of his one-week primary care review, at his request before a Las Vegas engagement in five weeks

## Referral question

Long-term prescription opioids and benzodiazepines from five prescribers, with fatigue, weight gain, constipation, daytime sleepiness and high blood pressure, in a 39-year-old touring singer who wants to change how he takes his medicines. Please assess for substance use disorders and advise on medication for opioid use disorder and a safe benzodiazepine plan. **S**

## Questions for the consultant

1. Does he meet DSM-5-TR criteria for opioid and sedative use disorders, and how severe?
2. Should he start buprenorphine, and how: in the office or at home, standard or low-dose start?
3. How should the two benzodiazepines be managed alongside buprenorphine, and at what taper pace?
4. What monitoring do you advise (urine testing, monitoring program, visit frequency, naloxone)?
5. How should care be planned around a Las Vegas engagement and a tour this autumn?

## Pertinent history

Opioids for about five years for back and neck pain from performing, and sedatives for sleep after shows. A hospital stay some years ago in which he was withdrawn from opioids. The monitoring program shows five prescribers and three pharmacies in the past year: hydromorphone 4 mg about five a day and oxycodone 10 mg with acetaminophen about three a day (about 145 MME), diazepam 10 mg three times daily, alprazolam 1 mg up to three a day, and phentermine 37.5 mg each morning (stopped today because of hypertension and glaucoma), with a nonprescription diphenhydramine sleep aid (also stopped). He takes more than prescribed, has tried to cut down, and has cravings; he has never injected and uses no illicit drugs or alcohol (AUDIT-C 0; DAST-10 7). PHQ-9 8 and GAD-7 9, item 9 scored 0; no suicidal thoughts; structured safety assessment done, firearms to be locked. Blood pressure 154/98, pulse 94; BMI 32.5; ALT 72, AST 52, GGT 78; hemoglobin A1c 5.8%; ECG normal, QTc 436 ms. STOP-Bang 6, Epworth 14; in-laboratory polysomnography booked. Glaucoma on latanoprost. Today: naloxone, a single-prescriber agreement, seven-day supplies of his current opioids and benzodiazepines at the verified doses, a locked box and take-back; he preferred to discuss buprenorphine with the specialist before starting. **S**

- Elvis Aron Presley was born in a two-room house in Tupelo, Mississippi, on January 8, 1935; his family moved to Memphis when he was 13. **D**
- He made his first record in 1953, became a national star in 1956, served in the Army in West Germany from 1958 to 1960, and by the 1970s performed long engagements in Las Vegas and toured constantly. In 1974 he played Las Vegas from January 26 to February 9, toured through much of March, including four shows in Memphis on March 16 and 17 and a recorded show there on March 20, played Lake Tahoe from May 16 to 26, toured again in mid-June, and took a few weeks off at Graceland from early July. **D**
- From October 15 to November 1, 1973, he was treated at Baptist Memorial Hospital in Memphis under an assumed name; at the 1981 trial of his physician, an internal medicine specialist who reviewed the records testified that the consulting physicians were "withdrawing him from narcotic drugs." **D**
- He had glaucoma, including an episode of acute angle-closure glaucoma in 1971, and was under the care of one ophthalmologist from 1971 on. **D**
- It was believed that he neither smoked nor drank alcohol. **D**

10 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Hemoglobin: 15.1 g/dL; Sodium: 139 mmol/L; Potassium: 4 mmol/L; Creatinine: 1 mg/dL; eGFR (CKD-EPI 1969): 98 mL/min/1.73 m²; Glucose: 104 mg/dL (high); Hemoglobin A1c: 5.8% (high); ALT: 72 U/L (high); AST: 52 U/L (high); GGT: 78 U/L (high); TSH: 2.1 mIU/L; Urine albumin-to-creatinine ratio: 14 mg/g{creat}; PHQ-9: 8; GAD-7: 9; DAST-10: 7; AUDIT-C: 0. All results are synthetic.

BP 154/98 mmHg; pulse 94 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 96% on room air; weight 109 kg; BMI 32.5 kg/m². All vital signs are synthetic.

## Current medications

- Hydromorphone 4 mg oral tablet, prescribed elsewhere as one tablet every four to six hours as needed for back and neck pain; taking about five a day (20 mg, 100 MME); continued by this clinic only, at the verified dose and seven days at a time, until the addiction medicine consultation **S**
- Oxycodone 10 mg and acetaminophen 325 mg oral tablet, prescribed by a second prescriber; taking about three a day (45 MME); continued by this clinic only, seven days at a time, until the consultation **S**
- Diazepam 10 mg oral tablet, one tablet three times daily, prescribed elsewhere for anxiety; continued by this clinic only, seven days at a time **S**
- Alprazolam 1 mg oral tablet, up to three a day as needed, prescribed by a fourth prescriber while on tour; continued by this clinic only, at the verified dose, seven days at a time **S**
- Latanoprost 0.005% eye drops, one drop in each eye at bedtime, prescribed by his ophthalmologist **S**
- Naloxone 4 mg nasal spray, one spray into one nostril for a suspected overdose, repeated in the other nostril after two to three minutes if needed; two-pack, with a second for the tour bag **S**
- Polyethylene glycol 3350, 17 g powder in a glass of water once daily **S**
- Senna 8.6 mg oral tablet, two tablets at bedtime **S**

## Plan so far

- Safe prescribing of controlled drugs: a brown-bag reconciliation of every medicine, a prescription drug monitoring program check before every controlled prescription, a written single-prescriber agreement with one pharmacy, urine drug testing explained as part of care, seven-day supplies at first, a locked box, and take-back of unused tablets; no controlled drug stopped abruptly. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025); Prescription Drug Monitoring Programs (PDMPs) (2026) **S**
- Overdose prevention: naloxone nasal spray at home and in the tour bag, two people around him taught to use it, no alcohol or other sedatives, and the danger of opioids with benzodiazepines and with the sleep apnea that is suspected explained. Guideline: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020) **S**
- Safety: a structured safety assessment, a written safety plan, firearms locked and unloaded with ammunition separate, the 988 Suicide & Crisis Lifeline, and safety review at every visit; PHQ-9 and GAD-7 at each review. Guideline: VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); Depression and Suicide Risk in Adults: Screening (2023); CMID: Clinical Monitoring Intelligence Database, hypertension, glaucoma, and depression, bipolar, and mood disorders monographs (2026) **S**
- Constipation on opioids: polyethylene glycol daily with senna as needed, fluids and fiber; a peripherally acting opioid antagonist only if these fail; an abdominal radiograph only for pain, distension or vomiting. Guideline: American Gastroenterological Association Institute Guideline on the Medical Management of Opioid-Induced Constipation (2019); American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation (2023) **S**
- Glaucoma: latanoprost continued, his ophthalmologist kept informed of every new medicine, no phentermine, decongestant or anticholinergic sleep aid, steroids only when essential and with his ophthalmologist's knowledge, and urgent care for eye pain with halos. Guideline: Primary Open-Angle Glaucoma Preferred Practice Pattern (2020); CMID: Clinical Monitoring Intelligence Database, hypertension, glaucoma, and depression, bipolar, and mood disorders monographs (2026) **S**
- Performing and touring: no medication change in the week before an engagement, weekly video visits while away, controlled prescriptions sent only to one named pharmacy, a written plan for missed doses, naloxone and any prescribed devices in the tour bag, and a letter he controls for venues. Guideline: The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020); Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) **S**
